Anti-ischaemic medication must be adapted to each patient's characteristics and preferences in patients with chronic coronary syndromes

Affiliations

• ¹ Department of Clinical Physiology, Nuclear Medicine and PET and Turku PET Centre, Turku University Hospital, Kiinamyllynkatu 4-8, Turku FI-20520, Finland.
• ² The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway, University Road, Galway H91 TK33, Ireland.
• ³ Department of Clinical Pharmacology, Sorbonne Université, INSERM CIC Paris-Est, AP-HP.Sorbonne Université, ICAN, Pitié-Salpêtrière Hospital, 47-83 Blvd de l'Hôpital, F-75013 Paris, France.